Breakthrough Throat & Nasal Swabs to fight COVID-19 pandemics
TAIZHOU, CHINA, March 19, 2022 /24-7PressRelease/ — Taizhou Kaimi Biotech Co., Ltd. (Kaimi Biotech) is announcing successful development and commercialization of an innovative Throat & Nasal Swab. QIDX Throat and Nasal Swab provides a reliable and robust tool for collecting various types of mucus samples and body fluids. Along with customized buffers, samples collected by QIDX Throat and Nasal Swab can be used for a number of types of analysis, including immunoassay antigen tests, qPCR/RT-qPCR tests and sequencing-based COVID-19 analysis.
QIDX Throat and Nasal Swab has a unique feature distinct from other commercial swabs with an innovative sample sufficiency indicator. The indicator will be fully activated from colorless to red only after enough sample has been collected.The sufficient indicator can help users know if enough samples have been collected to assure accurate and sensitive detection. QIDX Throat and Nasal Swab with sufficient indicator is reliable and robust. In addition, it helps to reduce human error and provides confidence for users, both medical professional and ordinary users.
The color appearing indicator uses food grade materials and is safe. The indicator has no leaching in saliva or nasal mucus. When using swabs to collect nasal or saliva samples, users, particularly non-medical professionals, often wonder how they know if enough sample has been collected. “QIDX Throat and Nasal Swab provides a convenient solution to this long unmet need ordinary swabs have failed to address for a long time,” said Otis Zhao, President of Kaimi Biotech.
“I am very proud to announce today that Kaimi’s technical team has solved this dilemma by introducing QIDX Throat and Nasal Swab. We are happy to partner with other companies to bring this revolutionary swab to more users, and help to fight Covid-19 pandemics. Please contact me if you are interested in collaborating with Kaimi Biotech.”
Kaimi Biotech, located in Jiangsu, China, develops and manufactures novel medical diagnostic products with our proprietary technologies. We firmly believe that excellent products rely on innovative materials and robust production processes. we are fully committed to investing on development of novel materials and manufacturing processes to deliver new products with great performance and help our customers solve challenging requirements of medical diagnostics.
For the original version of this press release, please visit 24-7PressRelease.com here